Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Shanmugam Uthamalingam , James L Januzzi Added: 3 years ago
Several cardiac biomarkers may aid in the diagnostic and prognostic evaluation of acute and chronic heart failure. In this article we discuss more novel and emerging applications of such established cardiac biomarkers in heart failure and review emerging data for several other promising markers. Novel Applications of Established Cardiac Biomarkers—Natriuretic Peptides B-type natriuretic peptide… View more

Heart Failure

MI/ACS
Yen-Wen Wu
Research Area(s) / Expertise:

Atherosclerosis and Hyperlipidemia

Heart Failure

Nuclear

 Job title: Director
Dr Yen-Wen Wu is the Director of theDivision of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital in New Taipei City, Taiwan. She is also an Adjunct Professor of the National Yang Ming Chiao Tung University. Dr Wu studied medicine at the College of Medicine at the National Taiwan University, gaining her Master's and PhD from the same institution. She undertook… View more
HFSA 22: PROVE-HF: Effect of Sacubitril/Valsartan in Patients with Mitral Regurgitation in Heart Failure with Preserved Ejection Fraction
Author(s): James L Januzzi Added: 1 year ago
HFSA 22 - Dr James Januzzi (Massachusetts General Hospital, US) outlines the findings of the PROVE-HF study, a trial which aimed to determine the effect of sacubitril/valsartan therapy on cardiac biomarkers in patients with mitral regurgitation in heart failure with reduced ejection fraction. Questions: 1. What was the ideology behind PROVE-HF? 2. What is the mechanism of action behind… View more

Heart Failure
Evangelos Giannitsis
Job title: Assistant Professor of Medicine in Heidelberg
Dr. Giannitsis, an Assistant Professor of Medicine based in Heidelberg, holds a medical degree from the University of Homburg. He pursued advanced training in internal medicine and cardiology at Lübeck University Hospital in Germany. Additionally, he completed a Ph.D. in internal medicine before assuming his current role in 2002. Dr. Giannitsis's research is centered on cardiac biomarkers,… View more
Author(s): James De Lemos Added: 3 years ago
Acute coronary syndromes (ACS) is an umbrella term comprising a spectrum of clinical conditions ranging from unstable angina to non-ST elevation myocardial infarction and ST elevation myocardial infarction. ACS begins when an atherosclerotic plaque ruptures or erodes and a platelet-fibrin clot obstructs coronary blood flow. These critical disorders are a major cause of emergency medical care and… View more

Imaging & Diagnostics

MI/ACS
COVID-19 Pandemic and Cardiovascular Disease
Author(s): Aniket S Rali , Andrew J Sauer Added: 3 years ago
In late December 2019, an outbreak of an unknown disease called a pneumonia of uncertain cause occurred in Wuhan, Hubei Province, China.1 Over the next few days, several independent laboratories identified the causative agent as a novel coronavirus.2–4 The WHO has temporarily named this virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the related infectious disease… View more

Vascular Disease and Surgery

Heart Failure
Author(s): Abelardo Martinez , Sandy Green , James L Januzzi Added: 3 years ago
Previously considered to be separate disease entities, the acute coronary syndromes (ACS) are somewhat arbitrarily divided on the basis of their electrocardiographic manifestations and are now thought to arise from a common disease process. Based on a number of factors, the severity of the ACS and, consequently, their attendant clinical risk may vary. The management of patients with ACS should… View more

MI/ACS
Jose Alvarez-Cardona
Research Area(s) / Expertise:

Heart Failure

Cardio-oncology

 Job title: Cardiologist
Dr Jose Alvarez-Cardona is aCardiologist and Assistant Professor atNew York University School of Medicine, New York, US.He received his medical degree from University of Puerto Rico School of Medicine.He specialises in cardiomyopathy and heart failure. His specialities include cardiac amyloidosis, cardiomyopathy and heart failure, congestive heart failure, heart transplant and left ventricular… View more
Author(s): Robert H Christenson Added: 3 years ago
Accurate and timely biochemical marker testing for aiding the diagnosis of myocardial infarction (MI) has been important for the appropriate disposition and treatment of patients for the past several decades. Creatine kinase (CK) muscle and brain (CK-MB) mass and myoglobin measurements were the standard up to the mid-1990s, when assays for the cardiac-specific isoforms of troponin I and troponin… View more

MI/ACS
Advanced Management Options for Massive and Submassive Pulmonary Embolism
Author(s): Sonika Malik , Anju Bhardwaj , Matthew Eisen , et al Added: 3 years ago
Pulmonary embolism (PE) is a common and serious manifestation of venous thromboembolism (VTE) and is an important cause of morbidity and mortality in the US. The incidence is estimated to be 50 per 100,000 but increases to 500 per 100,000 in the elderly.1 There is a wide spectrum of clinical severity with mortality estimates of 1–2 % in stable individuals and up to 30 % in patients presenting… View more

Anticoagulation

Intervention